Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease.

Ralph Kwame Akyea Joe Kai Nadeem QureshiBarbara IyenStephen F Weng

Published in: Heart (British Cardiac Society) (2019)

Optimal lowering of LDL-C is not achieved within 2 years in over half of patients in the general population initiated on statin therapy, and these patients will experience significantly increased risk of future CVD.

Keyphrases

cardiovascular disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
type diabetes
coronary artery disease
smoking cessation